GHEOR Expertise Specialized in global health economics and outcomes research chart studies with over twenty years of experience, MDA covers disease incidence and prevalence, burden of illness, treatment patterns, resource utilization, clinical outcomes, and patient-reported outcomes to support clinical trial design, market access, safety, and commercial strategy for life-sciences clients from startups to multinationals.

Acquisition Context Recent acquisition by RTI International creates a path to collaboration or cross selling within a broader RWE and analytics platform, enabling access to RTI’s pharma and biotechnology client base and the opportunity to jointly extend MDA’s chart study offerings.

RWE Growth Growing demand for real world evidence in drug development and market access presents a compelling sales angle to expand into observational studies, patient registries, and PRO analyses for life sciences customers.

Tech Modernization Tech stack based on Joomla MooTools jQuery and PHP suggests an opportunity to offer data integration, modernization, and scalable analytics and dashboard solutions to clients, improving delivery speed, security, and user experience.

Market Positioning Based in Parsippany New Jersey with global reach, MDA presents a nimble partner profile for small to mid-size life sciences firms seeking fast, customized GHEOR studies, with potential to scale through RTI collaboration or broader outreach to pharma clients.